Brief: Sernova Corporation Announces The Appointment Of Cynthia Pussinen As CEO
05/09/2023 12:05
Sept 5 (Reuters) - Sernova Corp SVA.TO :
* SERNOVA CORPORATION ANNOUNCES THE APPOINTMENT OF CYNTHIA
PUSSINEN AS CEO
* SERNOVA CORP - PHILIP TOLEIKIS, WHO HAS LED COMPANY SINCE
2009
AS PRESIDENT AND CEO WILL SERVE AS CHIEF TECHNOLOGY OFFICER
Source text for Eikon: ID:nGNX1v0Ppg
Further company coverage: SVA.TO
((Reuters.briefs@thomsonreuters.com;))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints